USDA potentially finds an ASF vaccine

게시됨 2021년 10월 4일

Tridge 요약

The USDA has developed a promising vaccine for African swine fever, a disease that has significantly impacted pig populations in China, Dominican Republic, and Haiti. The vaccine has shown to develop disease resistance in pigs within two weeks and in all animals within four weeks. The USDA is continuing to evaluate the vaccine's safety and efficacy in commercial settings, with plans to work with Navetko National Veterinary Joint Stock Company in Vietnam. The agency has also developed and patented five other experimental African swine fever vaccines and has issued seven licenses for research.
면책 조항: 위의 요약은 정보 제공 목적으로 Tridge 자체 학습 AI 모델에 의해 생성되었습니다.

원본 콘텐츠

The United States Department of Agriculture (USDA) has potentially found a vaccine to fight African swine fever, a disease that devastated pigs in China, was recently identified in the Dominican Republic, and even in Haiti. According to a posting on the agency's website, officials say the vaccine is "promising." According to the study, it develops disease resistance in one third of pigs within two weeks, and in all animals within four weeks. "This could play an important role in tackling the ongoing outbreak that threatens global pork supplies," said USDA study co-author Douglas Glade. US researchers will continue to determine the safety and efficacy of the vaccine in a commercial setting. They are now working with a commercial partner, Navetko National Veterinary Joint Stock Company, based in Vietnam. To date, the USDA has successfully developed and patented five experimental ASF vaccines and issued seven licenses to pharmaceutical companies to research them. ...

더 깊이 있는 인사이트가 필요하신가요?

귀사의 비즈니스에 맞춤화된 상세한 시장 분석 정보를 받아보세요.
'쿠키 허용'을 클릭하면 통계 및 개인 선호도 산출을 위한 쿠키 제공에 동의하게 됩니다. 개인정보 보호정책에서 쿠키에 대한 자세한 내용을 확인할 수 있습니다.